234 related articles for article (PubMed ID: 26531829)
1. Impacts of nicorandil on infarct myocardium in comparison with nitrate: assessed by cardiac magnetic resonance imaging.
Yamada K; Isobe S; Ishii H; Yokouchi K; Iwata H; Sawada K; Murohara T
Heart Vessels; 2016 Sep; 31(9):1430-7. PubMed ID: 26531829
[TBL] [Abstract][Full Text] [Related]
2. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
[TBL] [Abstract][Full Text] [Related]
3. Quantification of myocardial area at risk with T2-weighted CMR: comparison with contrast-enhanced CMR and coronary angiography.
Wright J; Adriaenssens T; Dymarkowski S; Desmet W; Bogaert J
JACC Cardiovasc Imaging; 2009 Jul; 2(7):825-31. PubMed ID: 19608131
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of cardiac troponin-I compared to creatine kinase-myocardial band for the assessment of infarct size as measured by cardiac magnetic resonance.
Di Chiara A; Dall'Armellina E; Badano LP; Meduri S; Pezzutto N; Fioretti PM
J Cardiovasc Med (Hagerstown); 2010 Aug; 11(8):587-92. PubMed ID: 20588136
[TBL] [Abstract][Full Text] [Related]
5. Coronary microvascular resistance index immediately after primary percutaneous coronary intervention as a predictor of the transmural extent of infarction in patients with ST-segment elevation anterior acute myocardial infarction.
Kitabata H; Imanishi T; Kubo T; Takarada S; Kashiwagi M; Matsumoto H; Tsujioka H; Ikejima H; Arita Y; Okochi K; Kuroi A; Ueno S; Kataiwa H; Tanimoto T; Yamano T; Hirata K; Nakamura N; Tanaka A; Mizukoshi M; Akasaka T
JACC Cardiovasc Imaging; 2009 Mar; 2(3):263-72. PubMed ID: 19356570
[TBL] [Abstract][Full Text] [Related]
6. Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial.
Patel MR; Worthley SG; Stebbins A; Dill T; Rademakers FE; Valeti US; Barsness GW; Van de Werf F; Hamm CW; Armstrong PW; Granger CB; Kim RJ
JACC Cardiovasc Imaging; 2010 Jan; 3(1):52-60. PubMed ID: 20129531
[TBL] [Abstract][Full Text] [Related]
7. Biomarker release after percutaneous coronary intervention in patients without established myocardial infarction as assessed by cardiac magnetic resonance with late gadolinium enhancement.
Vieira de Melo RM; Hueb W; Nomura CH; Ribeiro da Silva EE; Villa AV; Oikawa FTC; da Costa LMA; Rezende PC; Garzillo CL; Lima EG; Franchini Ramires JA; Kalil Filho R
Catheter Cardiovasc Interv; 2017 Jul; 90(1):87-93. PubMed ID: 28573785
[TBL] [Abstract][Full Text] [Related]
8. Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina.
Hwang J; Lee HC; Kim BW; Yang MJ; Park JS; Park JH; Lee HW; Oh J; Choi JH; Cha KS; Hong TJ; Song S; Kim SP
J Cardiol; 2013 Aug; 62(2):77-81. PubMed ID: 23731922
[TBL] [Abstract][Full Text] [Related]
9. Remote ischemic conditioning reduces myocardial infarct size and edema in patients with ST-segment elevation myocardial infarction.
White SK; Frohlich GM; Sado DM; Maestrini V; Fontana M; Treibel TA; Tehrani S; Flett AS; Meier P; Ariti C; Davies JR; Moon JC; Yellon DM; Hausenloy DJ
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt B):178-188. PubMed ID: 25240548
[TBL] [Abstract][Full Text] [Related]
10. Peri-infarct zone on early contrast-enhanced CMR imaging in patients with acute myocardial infarction.
Matsumoto H; Matsuda T; Miyamoto K; Shimada T; Mikuri M; Hiraoka Y
JACC Cardiovasc Imaging; 2011 Jun; 4(6):610-8. PubMed ID: 21679895
[TBL] [Abstract][Full Text] [Related]
11. Myocardium at risk in ST-segment elevation myocardial infarction comparison of T2-weighted edema imaging with the MR-assessed endocardial surface area and validation against angiographic scoring.
Fuernau G; Eitel I; Franke V; Hildebrandt L; Meissner J; de Waha S; Lurz P; Gutberlet M; Desch S; Schuler G; Thiele H
JACC Cardiovasc Imaging; 2011 Sep; 4(9):967-76. PubMed ID: 21920334
[TBL] [Abstract][Full Text] [Related]
12. Aborted myocardial infarction after primary percutaneous coronary intervention: magnetic resonance imaging insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
Patel MR; Westerhout CM; Granger CB; Brener SJ; Fu Y; Siha H; Kim RJ; Armstrong PW
Am Heart J; 2013 Feb; 165(2):226-33. PubMed ID: 23351826
[TBL] [Abstract][Full Text] [Related]
13. Impact of attenuated plaque as detected by intravascular ultrasound on the occurrence of microvascular obstruction after percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Shiono Y; Kubo T; Tanaka A; Tanimoto T; Ota S; Ino Y; Aoki H; Ozaki Y; Orii M; Shimamura K; Ishibashi K; Yamano T; Yamaguchi T; Hirata K; Imanishi T; Akasaka T
JACC Cardiovasc Interv; 2013 Aug; 6(8):847-53. PubMed ID: 23871509
[TBL] [Abstract][Full Text] [Related]
14. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Chia S; Senatore F; Raffel OC; Lee H; Wackers FJ; Jang IK
JACC Cardiovasc Interv; 2008 Aug; 1(4):415-23. PubMed ID: 19463339
[TBL] [Abstract][Full Text] [Related]
15. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials.
Kitakaze M; Asakura M; Kim J; Shintani Y; Asanuma H; Hamasaki T; Seguchi O; Myoishi M; Minamino T; Ohara T; Nagai Y; Nanto S; Watanabe K; Fukuzawa S; Hirayama A; Nakamura N; Kimura K; Fujii K; Ishihara M; Saito Y; Tomoike H; Kitamura S;
Lancet; 2007 Oct; 370(9597):1483-93. PubMed ID: 17964349
[TBL] [Abstract][Full Text] [Related]
16. The effect of nicorandil on cardiac function and clinical outcomes in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: a randomised trial.
Choe JC; Oh JH; Lee HC; Lee JW; Park TS; Park JH; Kim E; Kim MS; Ahn J; Park JS; Lee HW; Choi JH; Cha KS
Acta Cardiol; 2023 Oct; 78(8):880-888. PubMed ID: 36942830
[TBL] [Abstract][Full Text] [Related]
17. Coronary dilating effects of intracoronary nicorandil. Comparison with isosorbide dinitrate.
Ejima J; Kaneda K; Moriyama H; Ohmura I; Maruyama T; Kaji Y; Tsuda Y; Kanaya S; Fujino T; Niho Y
Jpn Heart J; 1995 Nov; 36(6):699-707. PubMed ID: 8627976
[TBL] [Abstract][Full Text] [Related]
18. Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction.
Ingkanisorn WP; Rhoads KL; Aletras AH; Kellman P; Arai AE
J Am Coll Cardiol; 2004 Jun; 43(12):2253-9. PubMed ID: 15193689
[TBL] [Abstract][Full Text] [Related]
19. Relation between the assessment of microvascular injury by cardiovascular magnetic resonance and coronary Doppler flow velocity measurements in patients with acute anterior wall myocardial infarction.
Hirsch A; Nijveldt R; Haeck JD; Beek AM; Koch KT; Henriques JP; van der Schaaf RJ; Vis MM; Baan J; de Winter RJ; Tijssen JG; van Rossum AC; Piek JJ
J Am Coll Cardiol; 2008 Jun; 51(23):2230-8. PubMed ID: 18534269
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
